According to Morgan Keegan, Johnson & Johnson JNJ Market Perform rating is reiterated.
Morgan Keegan said that Johnson & Johnson reported sales roughly in line with expectations, with EPS beating estimates due to a lower than expected tax rate. “We continue to rate JNJ shares Market Perform with a $68 price target, and note that investors who want exposure to one of the more stable companies in healthcare would do well to hold shares.”
KEY POINTS
Johnson & Johnson closed yesterday at $65.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in